Steroid hormone receptors in breast cancer management
- 1 October 1998
- journal article
- review article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 51 (3), 227-238
- https://doi.org/10.1023/a:1006132427948
Abstract
Estrogen and progesterone receptors (ER and PR) have now been studied in clinical breast cancer for more than 20 years. Positive receptor status correlates with favorable prognostic features...Keywords
This publication has 52 references indexed in Scilit:
- Characterization of Receptor Interaction and Transcriptional Repression by the Corepressor SMRTMolecular Endocrinology, 1997
- AIB1, a Steroid Receptor Coactivator Amplified in Breast and Ovarian CancerScience, 1997
- Coactivator and Corepressor Regulation of the Agonist/Antagonist Activity of the Mixed Antiestrogen, 4-HydroxytamoxifenMolecular Endocrinology, 1997
- The Partial Agonist Activity of Antagonist-Occupied Steroid Receptors Is Controlled by a Novel Hinge Domain-Binding Coactivator L7/SPA and the Corepressors N-CoR or SMRTMolecular Endocrinology, 1997
- Nuclear Receptor Repression Mediated by a Complex Containing SMRT, mSin3A, and Histone DeacetylaseCell, 1997
- Nuclear receptor coactivatorsCurrent Opinion in Cell Biology, 1997
- Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressorNature, 1995
- Correlations between estrogen receptor, progesterone receptor, and patient characteristics in human breast cancer.Journal of Clinical Oncology, 1984
- The value of estrogen and progesterone receptors in the treatment of breast cancerCancer, 1980
- Mechanism of Action of the Female Sex HormonesAnnual Review of Biochemistry, 1972